Inspire Medical Systems, Inc. (INSP): Price and Financial Metrics


Inspire Medical Systems, Inc. (INSP): $197.88

-28.65 (-12.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

INSP POWR Grades


  • INSP scores best on the Growth dimension, with a Growth rank ahead of 55.02% of US stocks.
  • The strongest trend for INSP is in Growth, which has been heading up over the past 198 days.
  • INSP's current lowest rank is in the Value metric (where it is better than 15.29% of US stocks).

INSP Stock Summary

  • INSP's went public 3.01 years ago, making it older than merely 8.76% of listed US stocks we're tracking.
  • With a price/sales ratio of 40.07, Inspire Medical Systems Inc has a higher such ratio than 93.79% of stocks in our set.
  • As for revenue growth, note that INSP's revenue has grown 54.21% over the past 12 months; that beats the revenue growth of 90.55% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Inspire Medical Systems Inc, a group of peers worth examining would be SWAV, PHR, AWH, BLDP, and PRLB.
  • INSP's SEC filings can be seen here. And to visit Inspire Medical Systems Inc's official web site, go to www.inspiresleep.com.

INSP Stock Price Chart Interactive Chart >

Price chart for INSP

INSP Price/Volume Stats

Current price $197.88 52-week high $252.25
Prev. close $226.53 52-week low $65.71
Day low $194.17 Volume 460,900
Day high $205.64 Avg. volume 223,901
50-day MA $217.95 Dividend yield N/A
200-day MA $173.18 Market Cap 5.38B

Inspire Medical Systems, Inc. (INSP) Company Bio


Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is based in Maple Grove, Minnesota.


INSP Latest News Stream


Event/Time News Detail
Loading, please wait...

INSP Latest Social Stream


Loading social stream, please wait...

View Full INSP Social Stream

Latest INSP News From Around the Web

Below are the latest news stories about Inspire Medical Systems Inc that investors may wish to consider to help them evaluate INSP as an investment opportunity.

Inspire Medical inks distribution deal to commercialize Inspire therapy in Japan

Inspire Medical Systems (INSP) announces an exclusive distribution agreement with Japan Lifeline Co., Ltd. ((JLL)), a service distributor of medical devices, to commercialize Inspire therapy in Japan.The parties entered into this agreement following successful completion of reimbursement review of Inspire therapy by the Minister of Health Labour and Welfare ((MLHW)).Formal...

Seeking Alpha | April 26, 2021

Inspire Medical Systems, Inc. Announces Exclusive Distribution Agreement with Japan Lifeline Co., Ltd to Commercialize Inspire Therapy in Japan

Reimbursement Review of Inspire Therapy Completed by Japan Ministry of Health Labour and Welfare (MHLW); National Health Insurance Payment Listing Expected in June 2021 Initial Inspire Therapy Implants in Japan Anticipated to Occur in Second Half of 2021 MINNEAPOLIS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), today announced an exclusive distribution agreement with Japan Lifeline Co., Ltd. (“JLL”), an independent full-service distributor of medical devices, to commercialize Inspire therapy in Japan. The parties entered into this agreement following successful ...

Yahoo | April 26, 2021

Investing in Sleep Apnea Companies

In this episode of Industry Focus: Wildcard, join Motley Fool contributor Brian Feroldi and host Emily Flippen as they talk about three companies trying to treat sleep apnea: ResMed (NYSE: RMD), Inspire Medical (NYSE: INSP), and Vivos Therapeutics (NASDAQ: VVOS). To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Today is Wednesday, March 24th, and I am your host, Emily Flippen.

Yahoo | April 9, 2021

Inspire Medical Systems, Inc. to Report First Quarter 2021 Financial Results on May 4, 2021

MINNEAPOLIS, April 06, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the first quarter 2021 after the close of trading on Tuesday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. Tuesday, May 4th @ 5:00 p.m. Eastern Time:Domestic: 877-407-0792International: 201-689-8263Conference ID: 13717525Webcast: http://public.viavid.com/index.php?id=143909 About Inspire Medical SystemsInspire is a medical technolo...

Yahoo | April 6, 2021

FDA Approves Inspire Medical’s Physician Programmer Platform; Street Says Buy

Medical technology company Inspire Medical Systems received approval from the U.S. Food and Drug Administration (FDA) for the Inspire physician programmer platform. Inspire Medical Systems (INSP) is focused on minimally invasive solutions for treating patients with obstructive sleep apnea. The approved platform provides four major enhancements to the company’s existing product. These enhancements include guided workflows, a new programmer cable that allows for ease of use, and improved telemetry range. The platform enables interface with Inspire cloud and uploading patient reports. It also supports the further integration of Inspire cloud, which can potentially provide remote programming, a feature that is currently under development.

Kailas Salunkhe on TipRanks | April 1, 2021

Read More 'INSP' Stories Here

INSP Price Returns

1-mo -4.35%
3-mo -10.97%
6-mo 17.79%
1-year 183.70%
3-year 722.79%
5-year N/A
YTD 5.20%
2020 153.46%
2019 75.64%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9 seconds.